Prognostic role of NLR in urinary cancers: a meta-analysis - Wikidata - wikimedia - TriplyDB

Prognostic role of NLR in urinary cancers: a meta-analysis

Prognostic role of NLR in urinary cancers: a meta-analysis

http://www.wikidata.org/entity/Q35124106

about

Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.Neutrophil to Lymphocyte Ratio (NLR) at the Time of Transurethral Resection of Bladder Tumor: A Large Retrospective Study and Analysis of Racial Differences.Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients.Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy.The prognostic significance of preoperative leukocytosis and neutrophil-to-lymphocyte ratio in patients who underwent radical cystectomy for bladder cancer Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy Preoperative neutrophil-lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study.Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients.Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.Predictive value of preoperative neutrophil-to-lymphocyte ratio on the prognosis of germ cell testicular tumors Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.Predictive role of hematologic parameters in testicular torsion The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3-5 chronic kidney disease.Prognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysis.Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer.Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.The Relationship between Hematological Indices and Autoimmune Rheumatic Diseases (ARDs), a Meta-Analysis.Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer.The authors reply: Predictive role of hematologic parameters in testicular torsion.INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.Can haematologic parameters be used for differential diagnosis of testicular torsion and epididymitis?Pre-treatment neutrophil-to-lymphocyte ratio predicts survival in patients with laryngeal cancer.The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer.Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy.Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer.The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.

P2860

Q26765926-510A4A3D-6727-449E-9154-91A796D7CC73 Q26769591-65AC84F8-61F9-4224-BB09-9612ADBC7BCB Q28083684-5BFB35BB-E0DC-47D6-BABB-E1C33C28FE94 Q28552296-6181EA24-ED73-45A9-BB4C-417D87095A18 Q33563230-C036EF3E-B45A-4D90-97B8-DFCC9AAD7809 Q33614530-8C0638A4-1410-48B9-B6E6-5355B0A15CFD Q35594253-0F69B371-5CAA-4CF2-9733-BF59A523FFB0 Q35817001-5A12C0B1-DB01-4536-8502-8273158E0C61 Q36069609-B06B1AF0-823B-4B01-B1D4-03C700EED8FA Q36195647-4F21DB4D-88F2-4F7E-A76C-E2BC982CDFCA Q36264797-38677D09-09B5-45DD-B383-B0C8B6F828A2 Q36654421-967C179D-5837-4CC9-9DBF-B68468B383D4 Q37170563-5CB5C6EA-5D19-47AB-9E34-553596C47764 Q37221777-70120407-2760-464B-9051-2E62168966C1 Q38623275-1576B453-2172-4410-9DB4-2573B7F7FE65 Q38833996-B455A8FB-8DD8-4F8A-B16C-F6213D47460C Q38922125-AE57A902-2164-4A0D-A2BF-762BA870D1F8 Q39093002-9F89B0D3-3CA4-4BE6-BE03-2F18328F4BCA Q39243899-F46FA17C-9F65-47B6-8CCD-54D1C09D44C2 Q39467452-551C814C-DED0-4768-B772-43AC2B334283 Q39679251-B2924FEA-0C71-4D94-A41D-26FB72000150 Q39739037-F23688E1-68ED-41D8-94C0-14ADA3FB0D95 Q40824744-8FFB8510-E550-4FA3-A5A8-64CD34752525 Q41116973-D88FED28-3BB0-4820-A24A-397E3153E417 Q41545194-3291ED35-D3CE-4A17-9002-18FA34842BFC Q42152624-EF3BAE50-EC6B-49CD-97E4-D75E1F200F45 Q42378488-6677EF99-7C42-4086-A48E-B4AB967729F4 Q42482055-0EFB6987-C0C9-4569-BFEB-7F49C449EC01 Q43688428-641DEC9F-EC53-43CC-97A5-A3DC909CB3F6 Q45934145-830A22BF-41EF-461C-8315-7AE478BAD5A4 Q48154176-5B8F3D83-ED10-409F-885E-E0E00D3D51A5 Q49334897-C37CDB9F-60C1-458C-8FB8-9D0628E86C32 Q50581538-C0CB17A8-0A1D-47B9-89ED-C86C64FCB656 Q53484321-0A83CEF8-D17D-4764-9EED-8BFA7EDFEB7A Q53981393-2BC8D282-3ED2-4B94-939A-C06E08CEE09F Q54964281-93727D2A-A0B0-4E41-9E32-6089136C9731

P2860

Prognostic role of NLR in urinary cancers: a meta-analysis

http://www.wikidata.org/entity/Q35124106

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prognostic role of NLR in urinary cancers: a meta-analysis

@ast

Prognostic role of NLR in urinary cancers: a meta-analysis

@en

type

label

Prognostic role of NLR in urinary cancers: a meta-analysis

@ast

Prognostic role of NLR in urinary cancers: a meta-analysis

@en

prefLabel

Prognostic role of NLR in urinary cancers: a meta-analysis

@ast

Prognostic role of NLR in urinary cancers: a meta-analysis

@en

P1433

Q35124106-5F5338E6-C47C-4B42-97A6-82CEFD0EA420

P1476

Q35124106-9EC03E98-A9C1-46D6-A562-7DB54D1264F8

P2093

Q35124106-7764591C-3FD9-4E07-A05D-2CBA5C05FD40

Q35124106-B6779957-2B45-4D9B-8007-38D2B04C5BD7

Q35124106-B8C3B48C-E318-4DA3-9593-5FFB51226486

P2860

Q35124106-1276DCBA-3277-49DF-8E65-CD5B7B706148

Q35124106-14EBD5E5-B8EB-48D9-9EC5-4ABF99805663

Q35124106-17D8FEF7-C2E1-4EB4-9DF8-21CC1B82BF6B

Q35124106-22168E01-7A80-4262-B7FD-1EBF82899F32

Q35124106-248BD31F-67AA-4119-A2B9-836A3AC339E1

Q35124106-36E25CB3-E33E-4612-839A-778EA4CBC0B8

Q35124106-3CD0D30B-C047-4CD0-BF0B-518B2CB27350

Q35124106-46815C24-E26D-40DE-ABF0-E66DEA0D873F

Q35124106-4996E1F4-1D35-46D9-9513-DE6AB5C2B94D

Q35124106-4C6B5CE5-DA6D-4139-843D-782FEF148DF3

P304

Q35124106-D35AF69A-FC1A-445C-AFC5-B9BA53FAD7F5

P31

Q35124106-32386b5a-6ae4-445d-a145-6f8ae8255a2d

Q35124106-7ABD7E72-77B9-4603-A3C2-51871AD6A506

P356

Q35124106-4B4B5273-9417-46EF-9D17-25CC0D699837

P407

Q35124106-D079977C-6FC0-4625-9ED5-2DAE634B1D38

P433

Q35124106-CF69031B-F355-4944-95B0-C973C25DFEFD

P478

Q35124106-E435309E-27E5-4B15-8C17-4B61683EE967

P577

Q35124106-D982EB05-F782-4C6A-B3DE-56130FFC0202

P5875

Q35124106-107C590A-BA95-478F-8299-D4375049CB91

P698

Q35124106-FA0ED2B2-9C71-4A9A-8F76-E7964E46151F

P932

Q35124106-D7AF230C-5D63-473A-B626-C60849780BD3

P356

JOURNAL.PONE.0092079

P1433

P1476

Prognostic role of NLR in urinary cancers: a meta-analysis

@en

P2093

Wen-Hui Qian

http://www.w3.org/2001/XMLSchema#string

Ya-Zhi Jiang

http://www.w3.org/2001/XMLSchema#string

Yong Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Cancer statistics, 2012

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Meta-analysis in clinical trials

Cancer-related inflammation

Statistical aspects of the analysis of data from retrospective studies of disease

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Practical methods for incorporating summary time-to-event data into meta-analysis

Sorafenib in advanced clear-cell renal-cell carcinoma

Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.

P304

e92079

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0092079

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260915545

http://www.w3.org/2001/XMLSchema#string

P698

24642859

http://www.w3.org/2001/XMLSchema#string

P932

3958449

http://www.w3.org/2001/XMLSchema#string